Literature DB >> 722731

Prodrugs of 9-beta-D-arabinofuranosyladenine. 1. Synthesis and evaluation of some 5'-(O-acyl) derivatives.

D C Baker, T H Haskell, S R Putt.   

Abstract

A number of 5'-(O-acyl) derivatives of 9-beta-D-arabinofuranosyladenine (ara-A, VIRA-A) (2a-k) were prepared by direct acylation of the parent nucleoside 1 in pyridine-N,N-dimethyliformamide. These compounds, designed as prodrugs for 1, offer a range of solubilities and lipophilicities indicating for several examples improved solubility and the potential for improved membrane transport over 1. All are resistant to deactivation by adenosine deaminase. Of special interest is the 5'-(O-valeryl) derivative 2d that shows a marked increase in antiviral activity over 1.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 722731     DOI: 10.1021/jm00210a009

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Selection of a derivative of the antiviral agent 9-[(1,3-dihydroxy-2-propoxy)-methyl]guanine (DHPG) with improved oral absorption.

Authors:  E J Benjamin; B A Firestone; R Bergstrom; M Fass; I Massey; I Tsina; Y Y Lin
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

2.  Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs.

Authors:  W M Shannon; G Arnett; D C Baker; S D Kumar; W I Higuchi
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

3.  Synthesis, physicochemical properties, and cytotoxicity of a series of 5'-ester prodrugs of 5-iodo-2'-deoxyuridine.

Authors:  M M Narurkar; A K Mitra
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

4.  Design and synthesis of vidarabine prodrugs as antiviral agents.

Authors:  Wei Shen; Jae-Seung Kim; Phillip E Kish; Jie Zhang; Stefanie Mitchell; Brian G Gentry; Julie M Breitenbach; John C Drach; John Hilfinger
Journal:  Bioorg Med Chem Lett       Date:  2008-12-10       Impact factor: 2.823

5.  Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin.

Authors:  R K Austin; P E Trefts; M Hintz; J D Connor; M F Kagnoff
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

6.  Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.

Authors:  M C Maillard; O Nikodijević; K F LaNoue; D Berkich; X D Ji; R Bartus; K A Jacobson
Journal:  J Pharm Sci       Date:  1994-01       Impact factor: 3.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.